$CLYM
Climb Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wellesley Hills, MA
CLYM chart
What traders are saying about $CLYM
Latest postsClimb Bio, Inc. news
- Piper Sandler reiterates Climb Bio stock rating after ASN data By Investing.com
Investing.com Canada ·
- BTIG reiterates Buy rating on Climb Bio, $32 price target
TradingView ·
- Wedbush Maintains Climb Bio(CLYM.US) With Buy Rating, Raises Target Price to $25
Moomoo ·
- Form 8K Climb Bio Inc For: 26 October By Investing.com
Investing.com India ·
- Guggenheim reiterates Climb Bio stock rating on kidney drug data By Investing.com
Investing.com South Africa ·
- Climb Bio reports 38% immunologic remission in kidney trial
Mugglehead Investment Magazine ·
- Climb Bio reports early data on budoprutug for kidney diseases
Investing.com ·
- Climb Bio unveils initial Phase 2 data for budoprutug in primary membranous nephropathy
Traders Union ·
- Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
Yahoo Finance ·
- One patient with kidney disease had 3 years of remission without steroids
Stock Titan ·
- Climb Bio, Mabworks announce additional Phase 1 data for CLYM116/MIL116
TipRanks ·
- Climb Bio Reports CLYM116 Phase 1 Data Supporting 12-Week Dosing
TradingView ·
Climb Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$59.9M | -$73.9M | -$35.1M | -$45.2M |
| Diluted EPS | $-0.88 | $-1.53 | $-1.30 | $-1.72 |
| Total assets (year end) | $167.7M | $217.2M | $110.5M | $135.0M |
| Cash and equivalents (year end) | $35.7M | $87.2M | $93.1M | $43.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Climb Bio, Inc.
- Ticker
- CLYM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wellesley Hills, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1768446
- Former names
- Eliem Therapeutics, Inc.
Frequently asked questions
What exchange is Climb Bio, Inc. listed on?
Climb Bio, Inc. trades on the Nasdaq under the ticker symbol CLYM.
What industry is Climb Bio, Inc. in?
Climb Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Climb Bio, Inc. headquartered?
Climb Bio, Inc.'s business address on file with the SEC is in Wellesley Hills, MA.
When does Climb Bio, Inc.'s fiscal year end?
Climb Bio, Inc.'s fiscal year ends on December 31.